These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Contralateral weakness following botulinum toxin for poststroke spasticity.
    Author: Thomas AM, Simpson DM.
    Journal: Muscle Nerve; 2012 Sep; 46(3):443-8. PubMed ID: 22907238.
    Abstract:
    INTRODUCTION: We describe 2 patients who received botulinum toxin A (BoNT) for poststroke spasticity and developed contralateral limb weakness. METHODS: Both patients received high doses of BoNT with large dilution volumes and injection in the proximal upper extremity muscles, and developed weakness of the contralateral upper limb. These patients then underwent electrodiagnostic testing of the affected limb. RESULTS: Repetitive nerve stimulation of the axillary and spinal accessory nerves revealed decrements of 23% and 16%, respectively. EMG revealed abnormal spontaneous activity and small polyphasic motor unit potentials with reduced recruitment. These findings indicated blockade of the neuromuscular junction. Both patients improved. CONCLUSIONS: Isolated weakness of the contralateral limb after BoNT injection for poststroke spasticity suggests diffusion of toxin through tissue planes from proximal upper extremity muscles, across the midline, to contralateral muscles. High doses of botulinum toxin, high dilution volumes, and injection of proximal upper extremity muscles appear to be risk factors for this adverse effect.
    [Abstract] [Full Text] [Related] [New Search]